Skip to main content
SpringerLink
Log in

Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration

Clinical Implications

  • Review Articles
  • Drug Interactions
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Drug-drug, drug-formulation and drug-meal interactions are of clinical concern for orally administered drugs that possess a narrow therapeutic index. This review presents the current status of information regarding interactions which may influence the gastrointestinal (GI) absorption of orally administered drugs.

Absorption interactions have been classified on the basis of rate-limiting processes. These processes are put in the context of drug and formulation physicochemical properties and oral input influences on variable GI physiology. Interaction categorisation makes use of a biopharmaceutical classification system based on drug aqueous solubility and membrane permeability and their contributions towards absorption variability. Overlaying this classification it is important to be aware of the effect that the magnitudes of drug dosage and volume of fluid administration can have on interactions involving a solubility rate limits.

GI regional differences in membrane permeability are fundamental to the rational development of extended release dosage forms as well as to predicting interaction effects on absorption from immediate release dosage forms. The effect of meals on the regional-dependent intestinal elimination of drugs and their involvement in drug absorption interactions is also discussed. Although the clinical significance of such interactions is certainly dependent on the narrowness of the drug therapeutic index, clinical aspects of absorption delays and therapeutic failures resulting from various interactions are also important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rowland M, Tozer TN, editors. Clinical pharmacokinetics. 3rd ed. Philadelphia: Williams & Wilkins, 1995: 119–36.

    Google Scholar 

  2. Carver PL, Fleisher D, Zhou SY, et al. Meal composition effects on the oral absorption of indinavir in HIV-infected patients. Pharm Res. In press.

  3. Pargal A, Kelkar MG, Nayak PJ. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations. Biopharm Drug Dispos 1996; 17(6): 511–9.

    Article  PubMed  CAS  Google Scholar 

  4. Lomaestro BM, Bailie GR. Absorption interactions with fluoroquinolones: 1995 update. Drug Saf 1995; 12(5): 314–33.

    Article  PubMed  CAS  Google Scholar 

  5. Deppermann KM, Lode H. Fluoroquinolones: interaction profile during enteral absorption. Drugs 1993; 45 Suppl. 3: 65–72.

    Article  PubMed  Google Scholar 

  6. Dongowski G, Neubert R, Haase H, et al. Interactions between food components and drugs: Pt 4. Influence of pectins and bile salts on propranolol absorption. Int J Pharm 1996 Nov 29; 144: 233–9.

    Article  CAS  Google Scholar 

  7. Huupponen R, Seppala P, Iisalo E. Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man. Eur J Clin Pharmacol 1984; 26(2): 279–81.

    Article  PubMed  CAS  Google Scholar 

  8. Russell TL, Berardi RR, Barnett JL, et al. Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women. Pharm Res 1993; 10(2): 187–96.

    Article  PubMed  CAS  Google Scholar 

  9. Sievers ML. A study of achlorhydria among southwestern American Indians. Am J Gastroenterol 1966; 45(2): 99–108.

    PubMed  CAS  Google Scholar 

  10. Holt PR, Rosenberg IH, Russell RM. Causes and consequences of hypochlorhydria in the elderly. Dig Dis Sci 1989; 34(6): 933–7.

    Article  PubMed  CAS  Google Scholar 

  11. Varis K, Ihamaki T, Harkonen M, et al. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol 1979; 14(2): 129–39.

    Article  PubMed  CAS  Google Scholar 

  12. Meddings JB. Intestinal permeability in Crohn’s disease. Aliment Pharmacol Ther 1997; 11 Suppl. 3: 47–56.

    PubMed  Google Scholar 

  13. Gubbins PO, Bertch KE. Drug absorption in gastrointestinal disease and surgery. Pharmacotherapy 1989; 9(5): 285–95.

    PubMed  CAS  Google Scholar 

  14. Gubbins PO, Bertch KE. Drug absorption in gastrointestinal disease and surgery: clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet 1991; 21(6): 431–47.

    Article  PubMed  CAS  Google Scholar 

  15. Youngberg CA, Berardi RR, Howatt WF, et al. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 1987; 32(5): 472–80.

    Article  PubMed  CAS  Google Scholar 

  16. Herzlich BC, Schiano TD, Moussa Z, et al. Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B 12 malabsorption. Am J Gastroenterol 1992; 87(12): 1781–8.

    PubMed  CAS  Google Scholar 

  17. Lake-Bakaar G, Elsakr M, Hagag N, et al. Changes in parietal cell structure and function in HIV disease. Dig Dis Sci 1996; 41(7): 1398–408.

    Article  PubMed  CAS  Google Scholar 

  18. Welling PG. Effects of food on drug absorption. Pharmacol Ther 1989; 43(3): 425–41.

    Article  PubMed  CAS  Google Scholar 

  19. Shafer RB, Levine AS, Mariette JM, et al. Do calories, osmolality, or calcium determine gastric emptying? Am J Physiol 1985; 248(4 Pt 2): 479–83.

    Google Scholar 

  20. Hunt JN. Does calcium mediate slowing of gastric emptying by fat in humans? Am J Physiol 1983; 244(1): 89–94.

    Google Scholar 

  21. Oberle RL, Chen TS, Lloyd C, et al. The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. Gastroenterology 1990; 99(5): 1275–82.

    PubMed  CAS  Google Scholar 

  22. Collins PJ, Horowitz M, Maddox A, et al. Effects of increasing solid component size of a mixed solid/liquid meal on solid and liquid gastric emptying. Am J Physiol 1996; 271(4 Pt 1): 549–54.

    Google Scholar 

  23. Camilleri M, Malagelada JR, Brown ML, et al. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 1985; 249(5 Pt 1): 580–5.

    Google Scholar 

  24. Meyer JH, Dressman J, Fink A, et al. Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterology 1985; 89(4): 805–13.

    PubMed  CAS  Google Scholar 

  25. Fleisher D, Lippert CL, Sheth N, et al. Nutrient effects on intestinal drug absorption. J Controlled Release 1990 Jan; 11: 41–9.

    Article  CAS  Google Scholar 

  26. Walter-Sack I. What is ‘fasting’ drug administration? On the role of gastric motility in drug absorption. Eur J Clin Pharmacol 1992; 42(1): 11–3.

    Article  PubMed  CAS  Google Scholar 

  27. Deppermann KM, Lode H, Hoffken G, et al. Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1989; 33(11): 1901–7.

    Article  PubMed  CAS  Google Scholar 

  28. Sadowski DC. Drug interactions with antacids: mechanisms and clinical significance. Drug Saf 1994; 11(6): 395–407.

    Article  PubMed  CAS  Google Scholar 

  29. Muck W, Ritter W, Dietrich H, et al. Influence of the antacid Maalox and the H2-antagonist Cimetidine on the pharmacokinetics of cerivastatin. Int J Clin Pharmacol Ther 1997; 35(6): 261–4.

    PubMed  CAS  Google Scholar 

  30. Sommers DK, van Wyk M, Snyman JR, et al. The effects of omeprazole-induced hypochlorhydria on absorption of theophylline from a sustained-release formulation. Eur J Clin Pharmacol 1992; 43(2): 141–3.

    Article  PubMed  CAS  Google Scholar 

  31. Chaudhuri TK, Fink S. Update: pharmaceuticals and gastric emptying. Am J Gastroenterol 1990; 85(3): 223–30.

    PubMed  CAS  Google Scholar 

  32. Lin JH, Chen IW, Vastag KJ, et al. pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs. Drug Metab Dispos 1995; 23(7): 730–5.

    PubMed  CAS  Google Scholar 

  33. Levy RH, Pitlick WH, Troupin AS, et al. Pharmacokinetics of carbamazepine in normal man. Clin Pharmacol Ther 1975; 17(6): 657–68.

    PubMed  CAS  Google Scholar 

  34. Yu LX, Crison JR, Amidon GL. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int J Pharm 1996 Aug 16; 140: 111–8.

    Article  CAS  Google Scholar 

  35. Bedford TA, Rowbotham DJ. Cisapride: drug interactions of clinical significance [published erratum appears in Drug Saf y1997; 17 (3): 196]. Drug Saf 1996; 15(3): 167–75.

    Article  PubMed  CAS  Google Scholar 

  36. Greiff JM, Rowbotham D. Pharmacokinetic drug interactions with gastrointestinal motility modifying agents. Clin Pharmacokinet 1994; 27(6): 447–61.

    Article  PubMed  CAS  Google Scholar 

  37. Koch KM, Parr AF, Tomlinson JJ, et al. Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time. Pharm Res 1993 Jul; 10: 1027–30.

    Article  PubMed  CAS  Google Scholar 

  38. Li AP, Maurel P, Gomez-Lechon MJ, et al. Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. Chem Biol Interact 1997; 107(1–2): 5–16.

    Article  PubMed  CAS  Google Scholar 

  39. Sinko PJ, Balimane PV. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats. Biopharm Drug Dispos 1998; 19(4): 209–17.

    Article  PubMed  CAS  Google Scholar 

  40. Pao LH, Zhou SY, Cook C, et al. Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. Pharm Res 1998; 15(2): 221–7.

    Article  PubMed  CAS  Google Scholar 

  41. Katori N, Aoyagi N, Kojima S. Effects of codeine on the agitating force and gastrointestinal transit time in dogs, for use in drug absorption studies. Biol Pharm Bull 1998; 21(4): 418–20.

    Article  PubMed  CAS  Google Scholar 

  42. Bryson JC, Dukes GE, Kirby MG, et al. Effect of altering small bowel transit time on sustained release theophylline absorption. J Clin Pharmacol 1989; 29(8): 733–8.

    PubMed  CAS  Google Scholar 

  43. Lewis SJ, Oakey RE, Heaton KW. Intestinal absorption of oestrogen: the effect of altering transit-time. Eur J Gastroenterol Hepatol 1998; 10(1): 33–9.

    Article  PubMed  CAS  Google Scholar 

  44. Miles C, Dickson P, Rana K, et al. CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs. Regul Pept 1997; 68(1): 9–14.

    Article  PubMed  CAS  Google Scholar 

  45. Shah VP, Hunt JP, Fairweather WR, et al. Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline. Biopharm Drug Dispos 1986; 7(1): 27–33.

    Article  PubMed  CAS  Google Scholar 

  46. Hendeles L, Weinberger M, Milavetz G, et al. Food-induced ‘dose-dumping’ from a once-a-day theophylline product as a cause of theophylline toxicity. Chest 1985; 87(6): 758–65.

    Article  PubMed  CAS  Google Scholar 

  47. Fleisher D. Gastrointestinal transport of peptides: experimential systems. In: Taylor MD, Amidon GL, editor. Peptide based drug design: controlling transport and metabolism. Washington, DC: ACS Professional Reference Books, 1995: 501–23.

    Google Scholar 

  48. Matthes I, Nimmerfall F, Sucker H. Mucus models for investigation of intestinal absorption: Pt 2. Mechanisms of drug interaction with intestinal mucus. Pharmazie 1992 Aug; 47: 609–13.

    PubMed  CAS  Google Scholar 

  49. Li C, Pao L-H, Li L, et al. Regional intestinal absorption and meal effects on LY303366 in acanine model. Pharm Sci 1998; 1(1 Suppl.): S10.

    Google Scholar 

  50. Nakanishi K, Nadai T, Masada M, et al. Effect of cyclodextrins on biological membrane: II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins. Chem Pharm Bull 1992; 40(5): 1252–6.

    Article  PubMed  CAS  Google Scholar 

  51. Bagchi D, Carryl OR, Tran MX, et al. Stress, diet and alcohol-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate. J Appl Toxicol 1998; 18(1): 3–13.

    Article  PubMed  CAS  Google Scholar 

  52. Goldstein DB. The effects of drugs on membrane fluidity. Annu Rev Pharmacol Toxicol 1984; 24: 43–64.

    Article  PubMed  CAS  Google Scholar 

  53. Friedlander G, Le Grimellec C, Amiel C. Increase in membrane fluidity modulates sodium-coupled uptakes and cyclic AMP synthesis by renal proximal tubular cells in primary culture. Biochim Biophys Acta 1990; 1022(1): 1–7.

    Article  PubMed  CAS  Google Scholar 

  54. Lu HH, Thomas J, Fleisher D. Influence of D-glucose-induced water absorption on rat jejunal uptake of two passively absorbed drugs. J Pharm Sci 1992; 81(1): 21–5.

    Article  PubMed  CAS  Google Scholar 

  55. Lu HH, Thomas JD, Tukker JJ, et al. Intestinal water and solute absorption studies: comparison of in situ perfusion with chronic isolated loops in rats. Pharm Res 1992;9(7): 894–900.

    Article  PubMed  CAS  Google Scholar 

  56. Lennernas H. Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? Pharm Res 1995; 12(11): 1573–82.

    Article  PubMed  CAS  Google Scholar 

  57. Zhou S, Zimmermann E, Pao L-H, et al. Intestinal metabolism and elimination of 5-aminosalicylic acid. Drug Metab Dispos. In press.

  58. Yuasa H, Amidon GL, Fleisher D. Peptide carrier-mediated transport in intestinal brush border membrane vesicles of rats and rabbits: cephradine uptake and inhibition. Pharm Res 1993; 10(3): 400–4.

    Article  PubMed  CAS  Google Scholar 

  59. Yuasa H, Fleisher D, Amidon GL. Noncompetitive inhibition of cephradine uptake by enalapril in rabbit intestinal brush-border membrane vesicles: an enalapril specific inhibitory binding site on the peptide carrier. J Pharmacol Exp Ther 1994; 269(3): 1107–11.

    PubMed  CAS  Google Scholar 

  60. Jezyk N, Fleisher D. The transport of pregabatin in rat intestine and Caco-2 Monolayers. Pharm Res 1999; 16(4): 519–26.

    Article  PubMed  CAS  Google Scholar 

  61. Stewart BH, Kugler AR, Thompson PR, et al. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 1993; 10(2): 276–81.

    Article  PubMed  CAS  Google Scholar 

  62. Kim JS, Oberle RL, Krummel DA, et al. Absorption of ACE inhibitors from small intestine and colon. J Pharm Sci 1994; 83(9): 1350–6.

    Article  PubMed  CAS  Google Scholar 

  63. Gidal BE, Maly MM, Kowalski JW, et al. Gabapentin absorption: effect of mixing with foods of varying macronutrient composition. Ann Pharmacother 1998; 32(4): 405–9.

    Article  PubMed  CAS  Google Scholar 

  64. Gidal BE, Maly MM, Budde J, et al. Effect of a high-protein meal on gabapentin pharmacokinetics. Epilepsy Res 1996; 23(1): 71–6.

    Article  PubMed  CAS  Google Scholar 

  65. Fleisher D, Johnson KC, Stewart BH, et al. Oral absorption of 21-corticosteroid esters: a function of aqueous stability and intestinal enzyme activity and distribution. J Pharm Sci 1986; 75(10): 934–9.

    Article  PubMed  CAS  Google Scholar 

  66. TenHoor CN, Stewart BH. Reconversion of fosphenytoin in the presence of intestinal alkaline phosphatase. Pharm Res 1995; 12(11): 1806–9.

    Article  PubMed  CAS  Google Scholar 

  67. Fleisher D, Bong R, Stewart BH. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs. Advanced Drug Delivery Rev 1996 May; 19: 115–30.

    Article  CAS  Google Scholar 

  68. Dunselman PH, Scaf AH, Kuntze CE, et al. Digoxin-felodipine interaction in patients with congestive heart failure. Eur J Clin Pharmacol 1988; 35(5): 461–5.

    Article  PubMed  CAS  Google Scholar 

  69. De Mey C, Brendel E, Enterling D. Carvedilol increases the systemic bioavailability of oral digoxin. Br J Clin Pharmacol 1990; 29(4): 486–90.

    Article  PubMed  Google Scholar 

  70. Carlton LD, Pollack GM, Brouwer KL. Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol. J Pharm Sci 1996; 85(5): 473–7.

    Article  PubMed  CAS  Google Scholar 

  71. Su SF, Huang JD. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metabol Dispos 1996; 24(2): 142–7.

    CAS  Google Scholar 

  72. Cavet ME, West M, Simmons NL. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 1996; 118(6): 1389–96.

    Article  PubMed  CAS  Google Scholar 

  73. Flicker G, Drewe J, Huwyler J, et al. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br J Pharmacol 1996; 118(7): 1841–7.

    Article  Google Scholar 

  74. Ameer B, Weintraub RA. Drug interactions with grapefruit juice. Clin Pharmacokinet 1997; 33(2): 103–21.

    Article  PubMed  CAS  Google Scholar 

  75. Zhang Y, Guo X, Lin ET, et al. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. Drug Metab Dispos 1998; 26(4): 360–6.

    PubMed  CAS  Google Scholar 

  76. Liedholm H, Melander A. Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation. Clin Pharmacol Ther 1986; 40(1): 29–36.

    Article  PubMed  CAS  Google Scholar 

  77. Melander A, Liedholm H, McLean A. Concomitant food intake does enhance the bioavailability and effect of hydralazine [letter]. Clin Pharmacol Ther 1985; 38(4): 475–6.

    Article  PubMed  CAS  Google Scholar 

  78. Liedholm H, Wahlin-Boll E, Hanson A, et al. Influence of food on the bioavailability of ‘real’ and ‘apparent’ hydralazine from conventional and slow-release preparations. Drug Nutr Interact 1982; 1(4): 293–302.

    PubMed  CAS  Google Scholar 

  79. Schusdziarra V, Harris V, Arimura A, et al. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. Endocrinology 1979; 104(6): 1705–8.

    Article  PubMed  CAS  Google Scholar 

  80. Ludden TM, Allerheiligen SR, Browne TR, et al. Sensitivity analysis of the effect of bioavailability or dosage form content on mean steady state phenytoin concentration. Ther Drug Monit 1991; 13(2): 120–5.

    Article  PubMed  CAS  Google Scholar 

  81. Tschanz C, Stargel WW, Thomas JA. Interactions between drugs and nutrients. Adv Pharmacol 1996; 35: 1–26.

    Article  PubMed  CAS  Google Scholar 

  82. Williams L, Hill Jr DP, Davis JA, et al. The influence of food on the absorption and metabolism of drugs: an update [see comments]. Eur J Drug Metab Pharmacokinet 1996; 21(3): 201–11.

    Article  PubMed  CAS  Google Scholar 

  83. Bechtol LD, Bessent CT, Perkal MB. Influence of food on the absorption of erythromycin esters and enteric coated erythromycin in single dose studies. Curr Ther Res Clin Exp 1979 May; 25: 618–25.

    CAS  Google Scholar 

  84. Polache A, Munck LK, Munck BG. Baclofen (beta-p-chlorophenyl-gamma-aminobutyric acid) transport across rat jejunum. Biochim Biophys Acta 1993; 1147(2): 267–72.

    Article  PubMed  CAS  Google Scholar 

  85. Stevenson CM, Radulovic LL, Bockbrader HN, et al. Contrasting nutrient effects on the plasma levels of an amino acid-like antiepileptic agent from jejunal administration in dogs. J Pharm Sci 1997; 86(8): 953–7.

    Article  PubMed  CAS  Google Scholar 

  86. Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am 1992; 21(3): 511–26.

    PubMed  CAS  Google Scholar 

  87. Fuhr U. Drug interactions with grapefruit juice: extent, probable mechanism and clinical relevance. Drug Saf 1998; 18(4): 251–72.

    Article  PubMed  CAS  Google Scholar 

  88. Lundahl J, Regardh CG, Edgar B, et al. Effects of grapefruit juice ingestion: pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol 1997; 52(2): 139–45.

    Article  PubMed  CAS  Google Scholar 

  89. McLean AJ, Isbister C, Bobik A, et al. Reduction of first pass hepatic clearance of propranolol by food. Clin Pharmacol Ther 1981 Jul; 30: 31–34.

    Article  PubMed  CAS  Google Scholar 

  90. McLean AJ, McNamara PJ, duSouich P, et al. Food, splanchnic blood flow, and bioavailability of drugs subject to first pass metabolism. Clin Pharmacol Ther 1978 Jul; 24: 5–10.

    PubMed  CAS  Google Scholar 

  91. Holt S, Heading RC, Carter DC, et al. Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet 1979; I(8117): 636–9.

    Article  Google Scholar 

  92. Gin H, Orgerie MB, Aubertin J. The influence of Guar gum on absorption of metformin from the gut in healthy volunteers. Horm Metab Res 1989; 21(2): 81–3.

    Article  PubMed  CAS  Google Scholar 

  93. Brown DD, Juhl RP. Decreased bioavailability of digoxin due to antacids and kaolin-pectin. N Engl J Med 1976; 295(19): 1034–7.

    Article  PubMed  CAS  Google Scholar 

  94. McCrindle JL, Li Kam WaTC, Barron W, et al. Effect of food on the absorption of frusemide and bumetanide in man. Br J Clin Pharmacol 1996; 42(6): 743–6.

    Article  PubMed  CAS  Google Scholar 

  95. Mizuta H, Kawazoe Y, Ogawa K. Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog. Chem Pharm Bull 1990; 38(10): 2810–3.

    Article  PubMed  CAS  Google Scholar 

  96. Lin HC, Doty JE, Reedy TJ, et al. Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. Am J Physiol 1989; 256(2 Pt 1): G404–11.

    PubMed  CAS  Google Scholar 

  97. Lin HC, Kim BH, Elashoff JD, et al. Gastric emptying of solid food is most potently inhibited by carbohydrate in the canine distal ileum. Gastroenterology 1992; 102(3): 793–801.

    PubMed  CAS  Google Scholar 

  98. Goldman P. Olestra: assessing its potential to interact with drugs in the gastrointestinal tract. Clin Pharmacol Ther 1997; 61(6): 613–8.

    Article  PubMed  CAS  Google Scholar 

  99. Lawson KD, Middleton SJ, Hassall CD. Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review. Drug Metab Rev 1997; 29(3): 651–703.

    Article  PubMed  CAS  Google Scholar 

  100. Manning WJ. Olestra and the FDA [letter]. N Engl J Med 1996; 335(9): 668–70.

    Article  PubMed  CAS  Google Scholar 

  101. Jandacek R. The effect of nonabsorbable lipids on the intestinal absorption of lipophiles. Drug Metab Rev 1982; 13: 695–714.

    Article  PubMed  CAS  Google Scholar 

  102. Richter WO, Jacob BG, Schwandt P. Interaction between fibre and lovastatin [letter]. Lancet 1991; 338(8768): 706.

    Article  PubMed  CAS  Google Scholar 

  103. Albert KS, Ayres JW, DiSanto AR, et al. Influence of kaolin-pectin suspension on digoxin bioavailability. J Pharm Sci 1978; 67(11): 1582–6.

    Article  PubMed  CAS  Google Scholar 

  104. Allen MD, Greenblatt DJ, Harmatz JS, et al. Effect of magnesium-aluminum hydroxide and kaolin-pectin on absorption of digoxin from tablets and capsules. J Clin Pharmacol 1981; 21(1): 26–30.

    PubMed  CAS  Google Scholar 

  105. Albert KS, DeSante KA, Welch RD, et al. Pharmacokinetic evaluation of a drug interaction between kaolin-pectin and clindamycin. J Pharm Sci 1978; 67(11): 1579–82.

    Article  PubMed  CAS  Google Scholar 

  106. Lieber CS. Mechanisms of ethanol-drug-nutrition interactions. J Toxicol Clin Toxicol 1994; 32(6): 631–81.

    Article  PubMed  CAS  Google Scholar 

  107. Rubin E, Gang H, Misra PS, et al. Inhibition of drug metabolism by acute ethanol intoxication: a hepatic microsomal mechanism. Am J Med 1970; 49(6): 801–6.

    Article  PubMed  CAS  Google Scholar 

  108. Carulli N, Manenti F, Gallo M, et al. Alcohol-drugs interaction in man: alcohol and tolbutamide. Eur J Clin Invest 1971; 1(6): 421–4.

    Article  PubMed  CAS  Google Scholar 

  109. Welling PG. Interactions affecting drug absorption. Clin Pharmacokinet 1984; 9(5): 404–34.

    Article  PubMed  CAS  Google Scholar 

  110. Welling PG. Effects of food on drug absorption. Annu Rev Nutr 1996; 16: 383–415.

    Article  PubMed  CAS  Google Scholar 

  111. Guengerich FP. Role of cytochrome P450 enzymes in drug-drug interactions. Adv Pharmacol 1997; 43: 7–35.

    Article  PubMed  CAS  Google Scholar 

  112. Resetarits DE, Bates TR. Apparent dose-dependent absorption of chlorothiazide in dogs. J Pharmacokinet Biopharm 1979; 7(5): 463–70.

    PubMed  CAS  Google Scholar 

  113. Morse GD, Fischl MA, Shelton MJ, et al. Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections. Antimicrob Agents Chemother 1996; 40(3): 767–71.

    PubMed  CAS  Google Scholar 

  114. Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents: drug interactions of clinical significance. Drug Saf 1998; 18(2): 83–97.

    Article  PubMed  CAS  Google Scholar 

  115. Koneru B, Cowart DT, Noorisa M, et al. Effect of increasing gastric pH with famotidine on the absorption and oral pharmacokinetics of the inotropic agent vesnarinone. J Clin Pharmacol 1998; 38(5): 429–32.

    PubMed  CAS  Google Scholar 

  116. Jung H, Medina R, Castro N, et al. Pharmacokinetic study of praziquantel administered alone and in combination with Cimetidine in a single-day therapeutic regimen. Antimicrob Agents Chemother 1997; 41(6): 1256–9.

    PubMed  CAS  Google Scholar 

  117. Jou MJ, Huang SC, Kiang FM, et al. Comparison of the effects of Cimetidine and ranitidine on the pharmacokinetics of disopyramide in man. J Pharm Pharmacol 1997; 49(11): 1072–5.

    Article  PubMed  CAS  Google Scholar 

  118. Marchbanks CR. Drug-drug interactions with fluoroquinolones. Pharmacotherapy 1993; 13(2 Pt 2): 23–8S.

    Google Scholar 

  119. Pan HY, DeVault AR, Swites BJ, et al. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia. Clin Pharmacol Ther 1990; 48(2): 201–7.

    Article  PubMed  CAS  Google Scholar 

  120. Guentert TW, Defoin R, Mosberg H. The influence of cholestyramine on the elimination of tenoxicam and piroxicam. Eur J Clin Pharmacol 1988; 34(3): 283–9.

    Article  PubMed  CAS  Google Scholar 

  121. Ahonen J, Olkkola KT, Neuvonen PJ. Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam. Eur J Clin Pharmacol 1997; 51(5): 415–9.

    Article  PubMed  CAS  Google Scholar 

  122. Jonsson TRAU. A study of the absorption of diltiazem from the distal parts of the gastrointestinal tract [abstract]. Eur J Clin Pharmacol 1989; 35 Suppl.: A243.

    Google Scholar 

  123. Homsy W, Caille G, duSouich P. The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit. Pharm Res 1995, 12(11): 1722–6.

    Article  PubMed  CAS  Google Scholar 

  124. duSouich P, Lery N, Varin F, et al. Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules. Biopharm Drug Dispos 1990; 11(2): 137–47.

    Article  CAS  Google Scholar 

  125. Warner P, Brouwer K, Hussey E, et al. Sumatriptan absorption from different regions of the human gastrointestinal tract. Pharm Res 1995; 12(1): 138–43.

    Article  PubMed  CAS  Google Scholar 

  126. Fowler P, Lacey L, Thomas M, et al. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol 1991; 31: 291–4.

    Article  PubMed  CAS  Google Scholar 

  127. Suttle AB, Brouwer KL. Regional gastrointestinal absorption of ranitidine in the rat. Pharm Res 1995; 12(9): 1311–5.

    Article  PubMed  CAS  Google Scholar 

  128. Williams M, Dukes GE, Heizer W, et al. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharm Res 1992; 9(9): 1190–4.

    Article  PubMed  CAS  Google Scholar 

  129. Gramatte T, Desoky EE, Klotz U. Site-dependent small intestinal absorption of ranitidine. Eur J Clin Pharmacol 1994; 46: 253–9.

    Article  PubMed  CAS  Google Scholar 

  130. Desmond P, Harman PJ, Gannoulis N, et al. The effect of an antacid and food on the absorption of Cimetidine and ranitidine. J Pharm Pharmacol 1990; 45(5): 352–4.

    Article  Google Scholar 

  131. Gramatte T, Richter K. Paracetamol absorption from different sites in the human small intestine. Br J Clin Pharmacol 1993; 37: 608–11.

    Article  Google Scholar 

  132. Wessels J, Koeleman HA, Boneschans B, et al. The influence of different types of breakfast on the absorption of paracetamol among members of an ethnic group. Int J Clin Pharmacol Ther Toxicol 1992; 30(6): 208–13.

    PubMed  CAS  Google Scholar 

  133. Delchier J, Gueret M, Vidon N, et al. Influence of digestive secretions and food on intestinal absorption of nicardipine. Eur J Clin Pharmacol 1988; 34: 165–71.

    Article  PubMed  CAS  Google Scholar 

  134. Staib A, Beermann D, Harder S, et al. Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF capsule). Am J Med 1989; 87(5A): 66–9S.

    Article  Google Scholar 

  135. Harder S, Fuhr U, Beermann D, et al. Ciprofloxacin absorption in different regions of the human gastrointestinal tract: investigations with the hf-capsule. Br J Clin Pharmacol 1990; 30: 35–9.

    Article  PubMed  CAS  Google Scholar 

  136. Forst R, Carlson J, Jr Dietz A, et al. Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast. J Clin Pharmacol 1989; 29: 953–5.

    Google Scholar 

  137. Haagen Nielsen O, Bondesen S. Kinetics of 5-aminosalicylic acid after jejunal instillation in man. Br J Clin Pharmacol 1983; 16(6): 738–40.

    Article  PubMed  CAS  Google Scholar 

  138. Schroder H, Campbell DES. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 1972 Jul–Aug; 13: 539–51.

    PubMed  CAS  Google Scholar 

  139. Ku DK, Elvin AT, Morrill B, et al. Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability. Clin Pharmacol Ther 1990 Jul; 48: 26–33.

    Article  Google Scholar 

  140. Sinko P, Hu P. Determining intestinal metabolism and permeability for several compounds in rats: implications on regional bioavailability in humans. Pharm Res 1996; 13(1): 108–13.

    Article  PubMed  CAS  Google Scholar 

  141. Seta Y, Higuchi F, Kawahara Y, et al. Design and preparation of Captopril sustained release dosage forms and their biopharmaceutical properties. Int J Pharm 1988 Feb; 41: 245–54.

    Article  CAS  Google Scholar 

  142. Mantyla R, Mannisto PT, Vuorela A, et al. Impairment of Captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol 1984 Nov; 22: 626–9.

    PubMed  CAS  Google Scholar 

  143. Singhvi SM, McKinstry DN, Shaw JM, et al. Effect of food on the bioavailability of Captopril in healthy subjects. J Clin Pharmacol 1982; 22(2–3): 135–40.

    PubMed  CAS  Google Scholar 

  144. Sinko PJ, Patel NR, Hu P. Site-specific oral absorption of didanosine: in situ characterization and correlation with extent of absorption in vivo. Int J Pharm 1994 Aug 29; 109: 125–33.

    Article  CAS  Google Scholar 

  145. Shyu WC, Knupp CA, Pittman KA, et al. Food-induced reduction in bioavailability of didanosine. Clin Pharmacol Ther 1991 Nov; 50: 503–7.

    Article  PubMed  CAS  Google Scholar 

  146. Hartman NR, Yarchoan R, Pluda JM, et al. Pharmacokinetics of 2′,3′-dideoxyinosine in patients with severe human immunodeficiency infection: Pt 2. Effects of different oral formulations and the presence of other medications. Clin Pharmacol Ther 1991 Sep; 50: 278–85.

    Article  PubMed  CAS  Google Scholar 

  147. Graul E, Loew D, Schuster O. Voraussetzung fur die entwichlung einer sinnvollen retard- und diuretilakombination. Therapiewoche 1985; 35: 4277–91.

    Google Scholar 

  148. Beermann B, Midskov C. Reduced bioavailability and effect of furosemide given with food. Eur J Clin Pharmacol 1986; 29(6): 725–7.

    Article  PubMed  CAS  Google Scholar 

  149. Gramatte T, Oertel R, Terhaag B, et al. Direct demonstration of small intestinal secretion and site-dependent absorption of the B-blocker talinolol in humans. Clin Pharmacol Ther 1996; 59: 541–9.

    Article  PubMed  CAS  Google Scholar 

  150. Terhaag B, Sahre H, Lange U, et al. Zum Einfluss der Nahrung auf die absorption von talinolol (Cordanum) am gesunden probanden. Z Klin Med 1991; 46: 1021–3.

    CAS  Google Scholar 

  151. Sahai J, Gallicano K, Garber G, et al. The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients. Br J Clin Pharmacol 1992; 33(6): 657–60.

    Article  PubMed  CAS  Google Scholar 

  152. Lotterer E, Ruhnke M, Trautmann M, et al. Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal. Eur J Clin Pharmacol 1991; 40(3): 305–8.

    Article  PubMed  CAS  Google Scholar 

  153. Dressman JB, Fleisher D, Amidon GL. Physicochemical model for dose-dependent drug absorption. J Pharm Sci 1984; 73(9): 1274–9.

    Article  PubMed  CAS  Google Scholar 

  154. Dressman JB, Fleisher D. Mixing-tank model for predicting dissolution rate control or oral absorption. J Pharm Sci 1986; 75(2): 109–16.

    Article  PubMed  CAS  Google Scholar 

  155. Welling PG, Barbhaiya RH. Influence of food and fluid volume on chlorothiazide bioavailability: comparison of plasma and urinary excretion methods. J Pharm Sci 1982; 71(1): 32–5.

    Article  PubMed  CAS  Google Scholar 

  156. Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12(3): 413–20.

    Article  PubMed  CAS  Google Scholar 

  157. TenHoor CN, Bakatselou V, Dressman J. Solubility of mefenamic acid under simulated fed- and fasted-state conditions. Pharm Res 1991 Sep; 8: 1203–5.

    Article  PubMed  CAS  Google Scholar 

  158. Dressman JB, Berardi RR, Elta GH, et al. Absorption of flurbiprofen in the fed and fasted states. Pharm Res 1992; 9(7): 901–7.

    Article  PubMed  CAS  Google Scholar 

  159. Corrigan OI. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations. Adv Exp Med Biol 1997; 423: 111–28.

    Article  PubMed  CAS  Google Scholar 

  160. Hamaguchi T, Shinkuma D, Irie T, et al. Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size. Int J Clin Pharmacol Ther Toxicol 1993; 31(7): 326–30.

    PubMed  CAS  Google Scholar 

  161. Stevenson CM, Kim J, Fleisher D. Colonic absorption of antiepileptic agents. Epilepsia 1997; 38(1): 63–7.

    Article  PubMed  CAS  Google Scholar 

  162. Zhi J, Melia AT, Koss-Twardy SG, et al. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers. J Clin Pharmacol 1996; 36(2): 152–9.

    PubMed  CAS  Google Scholar 

  163. Charman WN, Porter CJ, Mithani S, et al. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86(3): 269–82.

    Article  PubMed  CAS  Google Scholar 

  164. Gupta SK, Manfro RC, Tomlanovich SJ, et al. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration. J Clin Pharmacol 1990; 30(7): 643–53.

    PubMed  CAS  Google Scholar 

  165. Mueller EA, Kovarik JM, van Bree JB, et al. Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation. Pharm Res 1994; 11(1): 151–5.

    Article  PubMed  CAS  Google Scholar 

  166. Palma R, Vidon N, Houin G, et al. Influence of bile salts and lipids on intestinal absorption of griseofulvin in man. Eur J Clin Pharmacol 1986; 31(3): 319–25.

    Article  PubMed  CAS  Google Scholar 

  167. Charman WN, Rogge MC, Boddy AW, et al. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol 1993; 33(4): 381–6.

    PubMed  CAS  Google Scholar 

  168. Schaefer HG, Helmreich RL. The importance of human factors in the operating room [letter]. Anesthesiology 1994; 80(2): 479.

    Article  PubMed  CAS  Google Scholar 

  169. Doose DR, Minn FL, Stellar S, et al. Effects of meals and meal composition on the bioavailability of fenretinide. J Clin Pharmacol 1992; 32(12): 1089–95.

    PubMed  CAS  Google Scholar 

  170. Overdiek H, Hermens W, Merkus F. New insights into the pharmacokinetics of spironolactone. Clin Pharmacol Ther 1985 Oct; 38: 469–74.

    Article  PubMed  CAS  Google Scholar 

  171. Zimmermann T, Yeates RA, Laufen H, et al. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur J Clin Pharmacol 1994; 46(2): 147–50.

    Article  PubMed  CAS  Google Scholar 

  172. Perry CM, Noble S. Saquinavir soft-gel capsule formulation: a review of its use in patients with HIV infection. Drugs 1998; 55(3): 461–86.

    Article  PubMed  CAS  Google Scholar 

  173. Kakuda TN, Struble KA, Piscitelli SC. Protease inhibitors for the treatment of human immunodeficiency virus infection [published erratum appears in Am J Health Syst Pharm 1998 Apr 15; 55(8): 847]. Am J Health Syst Pharm 1998; 55(3): 233–54.

    PubMed  CAS  Google Scholar 

  174. Yeh KC, Deutsch PJ, Haddix H, et al. Single-dose pharmacokinetics of indinavir and the effect of food. Antimicrob Agents Chemother 1998; 42(2): 332–8.

    PubMed  CAS  Google Scholar 

  175. Gertz BJ, Holland SD, Kline WF, et al. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther 1995; 58(3): 288–98.

    Article  PubMed  CAS  Google Scholar 

  176. Feron B, Adair CG, Gorman SP, et al. Interaction of sucralfate with antibiotics used for selective decontamination of the gastrointestinal tract. Am J Hosp Pharm 1993, 50(12): 2550–3.

    PubMed  CAS  Google Scholar 

  177. Gai MN, Isla A, Andonaegui MT, et al. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Int J Clin Pharmacol Ther 1997; 35(12): 565–71.

    PubMed  CAS  Google Scholar 

  178. Messina MT, Devito JM. Commentary on ‘Influence of food on the bioavailability of verapamil’ [letter]. J Pharm Sci 1991; 80(7): 715–6.

    Article  PubMed  CAS  Google Scholar 

  179. Satoh C, Sakai T, Kashiwagi H, et al. Influence of cisapride on the pharmacokinetics and antihypertensive effect of sustained-release nifedipine. Intern Med 1996; 35(12): 941–5.

    Article  PubMed  CAS  Google Scholar 

  180. Galia E, Nicolaides E, Horter D, et al. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 1998; 15(5): 698–705.

    Article  PubMed  CAS  Google Scholar 

  181. Stewart BH, Chan OH, Jezyk N, et al. Discrimination between drug candidates using models for evaluation of intestinal absorption. Advanced Drug Delivery Rev 1997 Jan; 23: 27–45.

    Article  CAS  Google Scholar 

  182. Amidon GL, Sinko PJ, Fleisher D. Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res 1988; 5(10): 651–4.

    Article  PubMed  CAS  Google Scholar 

  183. Stewart BH, Chan OH, Lu RH, et al. Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm Res 1995; 12(5): 693–9.

    Article  PubMed  CAS  Google Scholar 

  184. Fagerholm U, Johansson M, Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm Res 1996; 13(9): 1336–42.

    Article  PubMed  CAS  Google Scholar 

  185. Lennernas H, Nylander S, Ungell AL. Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans. Pharm Res 1997; 14(5): 667–71.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of Michigan, Ann Arbor, Michigan, 48109-1065, USA

    David Fleisher,  David Fleisher, Cheng Li & Yuji Zhou

  2. Defence Medical Center, Taipei, Taiwan, Republic of China

    Li-Heng Pao

  3. GD Searle & Co., Skokie, Illinois, USA

    Aziz Karim

Authors
  1. David Fleisher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuji Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Li-Heng Pao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aziz Karim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Fleisher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fleisher, D., Li, C., Zhou, Y. et al. Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration. Clin Pharmacokinet 36, 233–254 (1999). https://doi.org/10.2165/00003088-199936030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199936030-00004

Keywords

Search

Navigation